The purpose of this study is to determine whether an inhaled steroid with a small particle
size can be an additional treatment option in patients with refractory eosinophilic asthma.
Phase:
Phase 4
Details
Lead Sponsor:
University of Nottingham
Collaborators:
Nottingham University Hospitals NHS Trust University Hospitals, Leicester